although
evid
persontoperson
transmiss
middl
east
respiratori
syndrom
coronaviru
merscov
household
healthcar
set
data
need
describ
better
understand
risk
factor
transmiss
rout
set
well
extent
diseas
sever
affect
transmiss
method
seroepidemiolog
investig
conduct
among
merscov
case
patient
case
household
contact
investig
transmiss
risk
abu
dhabi
unit
arab
emir
case
diagnos
januari
may
household
contact
approach
enrol
demograph
clinic
exposur
histori
data
collect
sera
screen
merscov
nucleocapsid
protein
enzymelink
immunosorb
assay
indirect
immunofluoresc
result
confirm
microneutr
assay
result
thirtyon
case
patient
asymptomat
mildli
symptomat
requir
oxygen
hospit
merscov
antibodi
detect
case
patient
avail
sera
includ
sever
symptomat
mildli
symptomat
asymptomat
case
patient
serolog
evid
merscov
transmiss
found
among
household
contact
avail
sera
conclus
transmiss
merscov
document
investig
mostli
asymptomat
mildli
symptomat
case
household
contact
result
implic
clinic
manag
case
formul
isol
polici
reduc
risk
transmiss
although
evid
persontoperson
transmiss
household
healthcar
set
data
need
describ
better
understand
risk
factor
transmiss
rout
set
well
extent
diseas
sever
affect
transmiss
data
would
import
public
health
respons
given
approxim
confirm
merscov
case
report
world
health
organ
describ
mildli
symptomat
asymptomat
januari
may
depart
healthabu
dhabi
doh
investig
laboratoryconfirm
case
conduct
extens
contact
investig
household
healthcar
set
investig
laboratoryconfirm
case
report
symptom
mild
ill
contact
case
patient
test
diagnost
pcr
assay
howev
result
could
includ
fals
neg
due
incub
period
investig
use
serolog
detect
merscov
antibodi
evalu
asymptomat
mildli
ill
case
patient
detect
merscov
antibodi
estim
transmiss
rate
known
case
household
contact
identifi
potenti
risk
factor
investig
occur
emir
abu
dhabi
occupi
uae
total
area
compris
region
abu
dhabi
capit
citi
al
region
al
dhafra
emir
abu
dhabi
popul
million
estim
al
region
border
oman
saudi
arabia
hous
second
largest
citi
emir
al
citi
al
citi
oasi
rest
region
primarili
consist
desert
mountain
al
dhafra
region
mainli
desert
rural
approxim
resid
popul
densiti
residentskm
laboratoryconfirm
merscov
case
n
emir
abu
dhabi
diagnos
januari
may
household
contact
n
elig
investig
case
conveni
sampl
ongo
merscov
outbreak
two
household
contact
test
merscov
initi
contact
investig
pcr
posit
elig
enrol
case
investig
figur
enrol
case
healthcar
worker
might
expos
anoth
cowork
also
live
case
household
therefor
enrol
case
result
either
household
healthcar
transmiss
prior
investig
initi
case
enrol
investig
expos
household
household
contact
defin
person
stay
least
night
locat
case
patient
day
prior
case
patient
symptom
onset
date
first
posit
specimen
case
patient
asymptomat
exclud
case
includ
palac
worker
highlevel
offici
associ
household
contact
also
exclud
merscov
case
identifi
investig
clinic
inform
includ
symptom
collect
use
intern
sever
acut
respiratori
emerg
infect
consortium
form
fill
real
time
healthcar
provid
subsequ
verifi
retrospect
chart
review
abu
dhabi
time
period
individu
test
posit
merscov
admit
healthcar
facil
observ
infect
control
regardless
symptom
statu
definit
case
sever
use
al
hosani
et
al
includ
follow
asymptomat
case
report
symptom
time
posit
test
record
healthcar
provid
medic
chart
mildli
symptomat
case
report
symptom
pharyng
rhinorrhea
cough
requir
oxygen
hospit
sever
symptomat
case
requir
supplement
oxygen
hospit
rang
nasal
cannula
mechan
ventil
use
data
collect
doh
surveil
merscov
case
household
merscov
case
patient
approach
household
contact
elig
investig
includ
identifi
contact
investig
associ
case
patient
perform
doh
offici
within
hour
notif
three
attempt
made
contact
household
respons
receiv
attempt
household
enrol
household
agre
enrol
given
appoint
local
diseas
prevent
screen
center
questionnair
administr
serum
collect
questionnair
administ
english
arab
interpret
avail
particip
nativ
languag
data
collect
includ
demograph
residencehousehold
descript
exposur
histori
merscov
case
healthcar
set
anim
travel
histori
medic
histori
includ
longterm
effect
report
case
patient
deceas
case
patient
proxi
complet
case
patient
questionnair
use
recal
realtim
reversetranscript
pcr
rrtpcr
result
obtain
doh
surveil
data
upper
ie
nasopharyng
oropharyng
lower
respiratori
tract
specimen
ie
sputum
bronchoalveolar
lavag
fluid
tracheal
aspir
analyz
use
rrtpcr
sheikh
khalifa
medic
center
laboratori
addit
laboratori
result
verif
perform
random
sampl
specimen
use
nucleocapsidbas
rrtpcr
serum
sampl
inactiv
use
rad
gamma
irradi
store
use
screen
serum
specimen
merscov
nucleocapsid
enzymelink
immunosorb
assay
elisa
perform
sheik
khalifa
medic
citi
abu
dhabi
uae
center
diseas
control
prevent
cdc
atlanta
georgia
titer
report
posit
recombin
full
length
merscov
nucleocapsid
protein
indirect
elisa
use
screen
serum
specimen
describ
alabdallat
et
al
serum
sampl
test
presenc
neutral
antibodi
merscov
use
microneutr
assay
mnt
neutral
titer
measur
reciproc
highest
serum
dilut
complet
inhibit
vero
cell
lysi
least
triplic
well
posit
neg
control
includ
mnt
perform
includ
backtitr
mockinfect
cell
titer
report
posit
work
live
merscov
done
biosafeti
level
contain
cdc
immunofluoresc
assay
ifa
perform
screen
sera
dilut
paraformaldehydefix
acetonemethanol
permeabil
merscov
strain
merscov
infect
uninfect
control
vero
cell
antihuman
immunoglobulin
g
fluorescein
isothiocyan
conjug
use
detect
antimerscov
antibodi
human
serum
nuclei
counterstain
allow
identif
individu
merscovinfect
cell
fluoresc
detect
use
zeiss
axioimag
fluoresc
microscop
posit
control
assay
serum
sampl
patient
infect
merscov
hu
posit
result
score
condit
met
cell
evenli
stain
instead
punctat
stain
fluoresc
intens
higher
neg
control
signal
intens
declin
serial
dilut
minimum
neg
control
includ
ifa
approxim
specimen
neg
nucleocapsid
elisa
screen
ifa
mnt
confirm
neg
result
merscov
antibodi
posit
defin
one
follow
test
ie
merscov
nucleocapsid
elisa
merscov
mnt
ifa
posit
mer
cov
mnt
posit
test
household
survey
data
enter
electron
form
epi
info
version
cdc
qualiti
control
assur
perform
epi
info
intellig
code
program
form
household
survey
data
merg
laboratori
result
descript
analysi
complet
differ
proport
compar
use
mantelhaenszel
test
differ
continu
variabl
compar
use
student
test
p
consid
statist
signific
data
analysi
merg
dataset
conduct
sa
version
softwar
sa
institut
cari
north
carolina
follow
local
custom
inform
consent
obtain
head
household
provid
consent
member
household
howev
individu
still
abl
declin
particip
investig
determin
doh
cdc
part
public
health
respons
research
therefor
subject
institut
review
board
review
thirtyfour
case
patient
household
includ
supplementari
tabl
household
resid
rang
size
interquartil
rang
iqr
median
individu
rang
live
household
day
prior
diagnosi
merscov
household
case
patient
half
merscov
case
patient
share
bathroom
other
household
household
report
air
condit
thirtyfour
case
household
contact
particip
tabl
femal
compris
higher
proport
case
patient
compar
household
contact
vs
case
patient
older
compar
household
contact
median
year
vs
year
case
patient
contact
al
region
abu
dhabi
emir
seventyon
percent
n
case
patient
report
work
healthcar
set
day
prior
diagnosi
nurs
repres
n
tabl
n
household
contact
work
healthcar
set
day
prior
case
patient
diagnosi
compar
household
contact
case
patient
less
frequent
report
visit
own
farm
vs
report
camel
exposur
frequent
vs
household
contact
report
follow
frequent
exposur
merscov
case
patient
hug
n
use
bathroom
n
share
meal
n
kiss
nosekiss
ie
rub
tip
nose
one
anoth
n
case
patient
report
higher
proport
underli
medic
condit
household
contact
includ
diabet
vs
p
hypertens
vs
p
kidney
failur
vs
p
heart
failur
vs
p
tabl
case
patient
also
report
take
medic
ill
frequent
contact
vs
three
case
patient
report
limit
activ
due
merscov
median
durat
day
iqr
day
tabl
normal
activ
resum
median
day
iqr
day
case
patient
report
asymptomat
report
mildli
symptomat
sever
symptomat
age
proport
underli
medic
condit
increas
symptom
sever
tabl
symptom
durat
notic
trend
symptom
sever
data
shown
sever
case
patient
treat
intens
care
unit
well
asymptomat
case
underli
diabet
hypertens
kidney
diseas
median
day
hospit
increas
symptom
sever
tabl
sera
obtain
case
patient
household
contact
among
case
patient
avail
sera
tabl
among
case
patient
detect
antibodi
merscov
age
year
median
age
year
compar
median
year
case
patient
without
detect
antibodi
tabl
p
number
day
pcr
posit
notabl
higher
among
detect
antibodi
compar
median
day
vs
day
p
describ
result
followup
merscov
case
patient
household
contact
emir
abu
dhabi
notabl
serolog
test
find
evid
merscov
transmiss
household
merscov
case
patient
investig
suggest
viral
transmiss
asymptomat
mildli
symptomat
individu
household
contact
readili
occur
sera
test
combin
differ
laboratori
assay
nucleocapsid
elisa
ifa
mnt
feel
confid
individu
identifi
neg
seroconvert
although
clear
evid
household
transmiss
household
enrol
investig
investig
result
show
evid
addit
household
transmiss
overal
find
support
current
recommend
home
isol
may
appropri
asymptomat
case
close
contact
ill
requir
hospit
consult
local
public
health
depart
investig
occur
mayjun
mani
case
patient
recruit
april
healthcareassoci
outbreak
al
region
hospit
kingdom
saudi
arabia
studi
found
healthcar
personnel
high
risk
infect
ill
rel
mild
could
unrecogn
highlight
potenti
undetect
transmiss
viru
other
investig
case
patient
tend
younger
year
report
work
healthcar
set
day
prior
diagnosi
expos
similar
previou
studi
case
patient
sever
diseas
higher
frequenc
comorbid
condit
requir
intens
care
includ
intub
recent
investig
south
korea
patient
higher
host
infect
includ
evalu
pcr
cycl
threshold
valu
along
higher
number
contact
like
transmit
merscov
like
primari
case
patient
investig
lower
host
infect
investig
found
asymptomat
mildli
symptomat
case
patient
detect
antibodi
find
detect
antibodi
asymptomat
mildli
symptomat
case
patient
studi
also
find
detect
antibodi
asymptomat
mildli
ill
case
seroconvers
occur
case
patient
studi
demonstr
usual
occur
within
first
month
ill
major
case
patient
detect
antibodi
found
persist
antibodi
respons
sever
month
initi
diagnosi
even
close
year
addit
case
patient
longer
durat
merscov
pcr
posit
detect
antibodi
indic
potenti
relationship
longer
viral
shed
seroconvers
previou
studi
demonstr
asymptomat
mildli
symptomat
case
patient
test
pcr
posit
week
lower
respiratori
tract
specimen
investig
serolog
result
provid
addit
evid
transmiss
household
contact
though
evid
set
suggest
limit
household
transmiss
also
low
rate
household
transmiss
report
hospitalbas
outbreak
robust
transmiss
studi
involv
larger
number
case
patient
repres
rang
clinic
demograph
characterist
contact
need
investig
risk
exposur
sever
limit
investig
first
serum
sampl
collect
vari
interv
ill
onset
case
patient
potenti
affect
serolog
result
durat
antibodi
respons
unknown
second
recal
bia
might
led
misclassif
symptom
sever
among
household
contact
howev
case
patient
minim
bia
reli
upon
retrospect
medic
chart
review
though
also
might
complet
sinc
depend
initi
healthcar
provid
histori
physic
third
case
patient
immedi
isol
hospit
pcrposit
result
discov
remov
household
set
might
reduc
exposur
household
contact
although
case
patient
resid
household
contact
time
contact
investig
last
investig
detect
household
transmiss
comment
behavior
exposur
would
increas
risk
among
household
contact
case
patient
summari
document
addit
household
transmiss
investig
includ
preponder
asymptomat
mildli
symptomat
confirm
merscov
case
patient
investig
find
support
recommend
consid
home
isol
asymptomat
mildli
ill
case
requir
hospit
use
proper
precaut
includ
face
mask
frequent
hand
wash
minim
exposur
case
patient
household
vaccin
antivir
merscov
current
avail
reduc
transmiss
effect
infect
control
manag
remain
major
prioriti
understand
transmiss
risk
differ
merscovinfect
patient
live
differ
set
import
data
must
factor
prevent
strategi
studi
humantohuman
transmiss
differ
set
conduct
inform
merscov
prevent
control
guidelin
supplementari
materi
avail
clinic
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
